Quipt Home Medical: A $5 Stock With A Good Chance To Double
An illogical sell-off gives investors a second chance to own QIPT
Quipt Home Medical has a history of outperformance fuelled by organic and inorganic growth.
A 28% decline since early April seems driven by external factors; the underlying business appears strong.
Back near $5, there’s a clear multi-year case for a double, while the defensive nature of the business provides some downside protection.